PMGC HOLDINGS INC
ELABNASDAQTrading Snapshot
- Day Range
- โ
- 52-Week Range
- $1.14 โ $1,344.00
- Volume (shares)
- โ
- Avg Volume (shares)
- โ
- Shares Outstanding
- 809,583
- Next Earnings
- โ
Fundamentals Snapshot
- Annual Revenue
- $590,084
- Last Q Revenue
- $1M
- P/E Ratio
- -0.0
- P/S Ratio
- 0.2x
- EPS (TTM)
- $-16.64
- Dividend Yield
- 0.00%
PMGC HOLDINGS INC
ELABFinancial history unavailable.
About PMGC HOLDINGS INC
PMGC Holdings Inc. functions as a biopharmaceutical firm, primarily dedicated to sourcing and advancing innovative aesthetic and therapeutic solutions. Its flagship product, EL-22, is a pioneering engineered probiotic designed to tackle the critical challenge of maintaining muscle mass during weight reduction regimens, especially those utilizing GLP-1 receptor agonists. Beyond its core operations, the company also engages in medical scientific research and development and manages various investment firms. Formerly known as Elevai Labs, Inc., the organization adopted its current name, PMGC Holdings Inc., in December 2024. Established in 2020, PMGC Holdings Inc. maintains its headquarters in Newport Beach, California.
Otter Score Breakdown
How it's scoredFive components, each rated 1โ5โ and equally weighted (20%), averaged to a 0โ100 score:๐ Quality โ gross margin๐ Growth โ revenue YoYโ๏ธ Valuation โ P/S ratioโก Momentum โ 30-day price change๐ง Dilution โ 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Latest News & Updates
News unavailable.